Cargando…
When Does Alzheimer′s Disease Really Start? The Role of Biomarkers
While Alzheimer’s disease (AD) classical diagnostic criteria rely on clinical data from a stablished symptomatic disease, newer criteria aim to identify the disease in its earlier stages. For that, they incorporated the use of AD’s specific biomarkers to reach a diagnosis, including the identificati...
Autores principales: | Lloret, Ana, Esteve, Daniel, Lloret, Maria-Angeles, Cervera-Ferri, Ana, Lopez, Begoña, Nepomuceno, Mariana, Monllor, Paloma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888399/ https://www.ncbi.nlm.nih.gov/pubmed/31698826 http://dx.doi.org/10.3390/ijms20225536 |
Ejemplares similares
-
Is Sleep Disruption a Cause or Consequence of Alzheimer’s Disease? Reviewing Its Possible Role as a Biomarker
por: Lloret, Maria-Angeles, et al.
Publicado: (2020) -
Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
por: Monllor, Paloma, et al.
Publicado: (2021) -
The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease
por: Lloret, Ana, et al.
Publicado: (2019) -
Obesity as a Risk Factor for Alzheimer’s Disease: Implication of Leptin and Glutamate
por: Lloret, Ana, et al.
Publicado: (2019) -
Is Oxidative Stress the Link Between Cerebral Small Vessel Disease, Sleep Disruption, and Oligodendrocyte Dysfunction in the Onset of Alzheimer’s Disease?
por: Lloret, Ana, et al.
Publicado: (2021)